{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:12:51Z","timestamp":1761959571604,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":162,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008169","name":"Minneapolis Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008169","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.lrr.2020.100212","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T16:20:56Z","timestamp":1592065256000},"page":"100212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Management of multiple myeloma during COVID-19 pandemic"],"prefix":"10.1016","volume":"14","author":[{"given":"YS","family":"Jethava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"Siegel, R.L., Miller K.D., Jemal, A., Cancer statistics, 2020. (1542-4863(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0001"},{"unstructured":"Kyle, R.A., et\u00a0al., Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades. (0008-543X (Print)).","key":"10.1016\/j.lrr.2020.100212_bib0002"},{"unstructured":"Li, Q., et\u00a0al., Early Transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. (1533-4406(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0003"},{"unstructured":"Guan, W.A.-O.X., et\u00a0al., Clinical characteristics of coronavirus disease 2019 in China. LID -10.1056\/NEJMoa2002032 [doi]. (1533-4406(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0004"},{"unstructured":"Chan, J.F., et\u00a0al., A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. (1474-547X (Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0005"},{"unstructured":"Bajema Kl Fau - Oster, A.M., et\u00a0al., Persons evaluated for 2019 novel coronavirus - United States, January 2020. (1545-861X (Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0006"},{"unstructured":"Huang, C., et\u00a0al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. (1474-547X (Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0007"},{"unstructured":"Wu, Z. and J.M. McGoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. LID -10.1001\/jama.2020.2648 [doi] FAU - Wu, Zunyou. (1538-3598(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0008"},{"unstructured":"Onder, G., G. Rezza, and S. Brusaferro, Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. LID -10.1001\/jama.2020.4683[doi] FAU - Onder, Graziano. (1538-3598(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0009"},{"unstructured":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020. (1545-861X (Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0010"},{"issue":"8","key":"10.1016\/j.lrr.2020.100212_bib0011","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/leu.2014.70","article-title":"Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma","volume":"28","author":"Affer","year":"2014","journal-title":"Leukemia"},{"unstructured":"Mehta, P., et\u00a0al., COVID-19: consider cytokine storm syndromes and immunosuppression. (1474-547X (Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0012"},{"unstructured":"Chen, N., et\u00a0al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. (1474-547X (Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0013"},{"unstructured":"Zhou, F., et\u00a0al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.(1474-547X (Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0014"},{"unstructured":"Wu, C., et\u00a0al., Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. LID -10.1001\/jamainternmed.2020.0994 [doi]. (2168-6114(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0015"},{"unstructured":"Shi, S., et\u00a0al., Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. LID -10.1001\/jamacardio.2020.0950 [doi]. (2380-6591(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0016"},{"unstructured":"Liu, Y., et\u00a0al., Viral dynamics in mild and severe cases of COVID-19. LID -S1473-3099(20)30232-2[pii] LID -10.1016\/S1473-3099(20)30232-2 [doi] FAU - Liu, Yang. (1474-4457(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0017"},{"unstructured":"Wong, H.Y.F.A.-O.h.o.o., et\u00a0al., Frequency and distribution of chest radiographic findings in COVID-19 positive patients. (1527-1315(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0018"},{"unstructured":"Shi, H., et\u00a0al., Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. (1474-4457(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0019"},{"unstructured":"Zhao, W., et\u00a0al., Relation between chest ct findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. (1546-3141(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0020"},{"unstructured":"Bai, H.X., et\u00a0al., Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. (1527-1315(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0021"},{"doi-asserted-by":"crossref","unstructured":"Patel, A. and D.B. Jernigan, Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020. (1545-861X (Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0022","DOI":"10.1111\/ajt.15805"},{"unstructured":"Wang, D., et\u00a0al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. LID -10.1001\/jama.2020.1585 [doi]. (1538-3598(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0023"},{"unstructured":"Arentz, M., et\u00a0al., Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. LID -10.1001\/jama.2020.4326 [doi] FAU - Arentz, Matt. (1538-3598(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0024"},{"unstructured":"Zhang, L., et\u00a0al., Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. LID -S0923-7534(20)36383-3[pii] LID -10.1016\/j.annonc.2020.03.296 [doi]. (1569-8041(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0025"},{"unstructured":"Kutikov, A., et\u00a0al., A War on two fronts: cancer care in the time of COVID-19. LID -10.7326\/M20-1133 [doi] FAU - Kutikov, Alexander. (1539-3704(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0026"},{"unstructured":"Kyle, R.A., et\u00a0al., Review of 1027 patients with newly diagnosed multiple myeloma. (0025-6196(Print)).","key":"10.1016\/j.lrr.2020.100212_bib0027"},{"unstructured":"Moreau, P., et\u00a0al., Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study. (1474-5488(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0028"},{"issue":"7","key":"10.1016\/j.lrr.2020.100212_bib0029","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s41375-019-0384-1","article-title":"Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance","volume":"33","author":"Kumar","year":"2019","journal-title":"Leukemia"},{"unstructured":"Tomblyn, M., et\u00a0al., Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. (1523-6536(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0030"},{"issue":"6","key":"10.1016\/j.lrr.2020.100212_bib0031","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3324\/haematol.2011.054015","article-title":"Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study","volume":"97","author":"Kristinsson","year":"2012","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.lrr.2020.100212_bib0032","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CVI.00021-11","article-title":"Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance","volume":"18","author":"Karlsson","year":"2011","journal-title":"Clin Vaccine Immunol"},{"unstructured":"Lai, C.C., et\u00a0al., Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. (1872-7913(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0033"},{"unstructured":"Gao, J., Z. Tian, and X. Yang, Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. (1881-7823(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0034"},{"unstructured":"Zhang, X., et\u00a0al., First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab. (2473-9537(Electronic)).","key":"10.1016\/j.lrr.2020.100212_bib0035"},{"key":"10.1016\/j.lrr.2020.100212_bib0036","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","author":"Grein","year":"2020","journal-title":"New Eng J Med"},{"unstructured":"World Health Organization Director-General's opening remarks at the media briefing on COVID-19 - February 24 2020. https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19\u201324-february-2020(Accessed on February 26, 2020).","key":"10.1016\/j.lrr.2020.100212_bib0037"},{"unstructured":"Centers for Disease Control and Prevention. Interim guidelines for collecting, handling, and testing clinical specimens from persons under investigation (PUIs) for coronavirus disease 2019 (COVID-19). February 14, 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-nCoV\/lab\/guidelines-clinical-specimens.html (Accessed on March 15, 2020).","key":"10.1016\/j.lrr.2020.100212_bib0038"},{"unstructured":"World Health Organization. Coronavirus disease (COVID-19) technical guidance: Surveillance and case definitions. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/surveillance-and-case-definitions (Accessed on February 28, 2020).","key":"10.1016\/j.lrr.2020.100212_bib0039"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048920300182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048920300182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:08:21Z","timestamp":1761959301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048920300182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":39,"alternative-id":["S2213048920300182"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2020.100212","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of multiple myeloma during COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2020.100212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100212"}}